Professional Documents
Culture Documents
Activity No. 1 - Dalumpines
Activity No. 1 - Dalumpines
DRUG STUDY
Generic Name Brand Name Uses Ideal Dose Peak Effect Duration of Action
Atorvastatin calcium Atorvast-Natrapharm Reduction of risk of MI and 80 mg/ Once daily 1-2 hr 14 hrs
stroke in patient with type 2 PO
diabetes and in those with
multiple risk factors for CAD
(such as age 55 or older,
smoking, hypertension, low
HDLC, family history of
early CAD) but no clinical
evidence of CAD
POLYTECHNIC COLLEGE OF DAVAO DEL SUR
MacArthur Highway, Digos City
DRUG STUDY
Generic Name Brand Name Uses Ideal Dose Peak Effect Duration of Action
Atenolol Therabloc Management of hypertension, 100 mg/ once daily 2-4 hr 6-9 hr
Management of angina pectoris, PO
Prevention of MI.
POLYTECHNIC COLLEGE OF DAVAO DEL SUR
MacArthur Highway, Digos City
DRUG STUDY
Generic Name Brand Name Uses Ideal Dose Peak Effect Duration of Action
AMOXICILLIN Ambimox Reduction of risk of MI and 500 mg/ q12h PO 1-2 hr 1-1.3 hr
stroke in patient with type 2
diabetes and in those with
multiple risk factors for CAD
(such as age 55 or older,
smoking, hypertension, low
HDLC, family history of
early CAD) but no clinical
evidence of CAD
POLYTECHNIC COLLEGE OF DAVAO DEL SUR
MacArthur Highway, Digos City
DRUG STUDY
Generic Name Brand Name Uses Ideal Dose Peak Effect Duration of Action
DRUG STUDY
Generic Name Brand Name Uses Ideal Dose Peak Effect Duration of Action
DRUG STUDY
Generic Name Brand Name Uses Ideal Dose Peak Effect Duration of Action
CLOPIDOGREL Saphlopid Reduction of atherosclerotic 75 mg/ Once daily 3-7 days 8 hr (active metabolite)
events (MI, stoke, vascular PO
death) in patients at risk for
such events including recent
MI, acute coronary syndrome
(unstable angina/non-Q-wave
MI), stroke, or peripheral
vascular disease.
Name: Genille Jamie Leanne O. Dalumpines Year & Course: BSN-2B